✦ LIBER ✦

Results of EORTC phase III trial 22931 comparing, postoperatively, radiotherapy (RT) to concurrent chemo-radiotherapy (RT-CT) with high dose cisplatin in locally advanced head and neck (H&N) carcinomas (SCC)

✍ Scribed by J. Bernier; M. van Glabbeke; C. Domenge; P. Wibault; M. Ozsahin; K. Matuszewska; M. Bolla; P. Maingon; F. Rolland; F. Cognetti; J.L. Lefèbvre; V. Budach

Book ID: 117658842
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 168 KB
Volume: 37
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(01)81481-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

149 Neoadjuvant docetaxel/cisplatin/fluo

149 Neoadjuvant docetaxel/cisplatin/fluorouracill (TPF) before concurrent chemo-radiotherapy (CT-RT) versus concomitant CT-RT alone in locally advanced squamous cell carcinoma (SCC) of head and neck. A phase II feasibility study

✍ M.G. Ghi; A. Paccagnella; P. D'amanzo; C.A. Mione; S. Fasan; R. Carnuccio; C. Ma 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 305 KB

Hyperfractionated radiotherapy (Hfx RT)

Hyperfractionated radiotherapy (Hfx RT) with or without concurrent low-dose daily cisplatin (CDDP) in locally advanced unresectable squamous cell carcinoma of the head and neck (SCC H&N). A prospective randomized trial

✍ B. Jeremic; Y. Shibamoto; B. Milicic; N. Nikolic; A. Dagovic 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 186 KB

825 Poster Standard fraction (CF) or hyp

825 Poster Standard fraction (CF) or hyperfractionated radiotherapy (Hfx RT) with or without concurrent low-dose daily platinum chemotherapy (CHT) in patients with locally advanced non-metastatic squamous cell carcinoma of the head and neck (SCC H&N). Almost perfect retrospective trial

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 159 KB